21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Method of treating cancers using beta-lapachone or analogs or derivatives thereof
#17102Solubility of hydrophobic drugs with a compound having a carboxylic acid moiety
#17103TREATMENT OF PATIENTS WITH CHRONIC PULMONARY DISEASES AND NUTRITIONAL COMPOSITIONS THEREFORE
#17104Uses of Kinase Inhibitors and Compositions Thereof
#17105Accelerated opiate dependence detoxification process
#17106Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
#17107Method of treating symptoms of hormonal variations
#17108PHARMACEUTICAL COMPOSITION FOR REDUCING THE RISKS ASSOCIATED WITH CARDIOVASCULAR AND CEREBROVASCULAR DISEASES
#17109RE-EPITHELIALIZING PHARMACEUTICAL COMPOSITIONS COMPRISING XANTHAN GUM
#17110COMPOSITION FOR PROMOTING COGNITIVE ATTRIBUTES
#17111Method and compositions for improving pulmonary hypertension
#17112COMPOSITIONS FOR DELIVERING PARATHYROID HORMONE AND CALCITONIN
#17113Methods of suppressing microglial activation
#17114Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
#17115Compositions and methods for detection of lysosomal storage disease
#17116COMPOSITIONS AND METHODS FOR TREATING PARASITIC INFECTIONS
#17117Formulation and method of making a topical pain relief composition
#17118Cosmetology product for skin and hair
#17119Formulations useful in the treatment of male and female impotence
#17120Medicated production for local use based on natural materials
#17121Composition for relieving discomfort
#17122Calcium Potassium Ferrocyanide, a prophylactic mixture comprising this compound and the use thereof for decorporation of Radiocesium in subjects affected by nuclear radiation
#17123Aspartame and citrate flavored phosphate salt laxative
#17124Microparticle preparation and medical composition
#17125Dosage Form Containing Oxycodone and Naloxone
#17126Dosage Forms Providing Controlled and Immediate Release of Cholesteryl Ester Transfer Protein Inhibitors and Immediate Release of Hmg-Coa Reductase Inhibitors
#17127HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
#17128Diindolylmethane for the treatment of HPV infection
#17129METHODS FOR REDUCING NEOVASCULARIZATION OR EDEMA
#17130METHODS AND COMPOSITIONS FOR REGENERATING CONNECTIVE TISSUE
#17131Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
#17132RECOMBINANT VIRUS EXPRESSING FOREIGN DNA ENCODING FELINE CD80, FELINE CD86, FELINE CD28, OR FELINE CTLA-4 AND USES THEREOF
#17133Algae and cancer treatment
#17134Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
#17135Therapeutic combination of a VEGF antagonist and anti-hypertensive agent
#17136Formulations including monovalent alginate to enhance effectiveness of administered digestive enzymes
#17137Composition comprising pyrithione or a polyvalent metal salt of a pyrithione and furametpyr
#17138Compounds, compositions and methods for controlling biofilms and bacterial infections
#17139Compositions Comprising Extracts from Sanguinaria or Macleaya
#17140EGFR inhibitors promote axon regeneration
#17141Treatment of metabolic syndrome with norfluoxetine
#17142Methods of wound care and treatment
#17143METHOD AND MATERIAL FOR IN SITU CORNEAL STRUCTURAL AUGMENTATION
#17144Use of a blood-flow decrease preventing agent in conjunction with insufflating gas
#17145Pharmaceutical Compositions For the Treatment of Disease and/or Symptoms in Arthritis
#17146METHOD FOR INCREASING SEROTONIN LEVELS IN A PERSON BY ADMINISTRATION OF A COMPOSITION INCORPORATING (-)HYDROXYCITRIC ACID, AND RELATED COMPOSITIONS THEREOF
#17147Non-standard amino acid conjugates of amphetamine and processes for making and using the same
#17148Mixtures of aromatic esters for marking or tagging organic products, marker compositions comprising the same and manufacturing methods thereof
#17149Compositions For Treating Flushing And Lipid-Associated Disorders Comprising Niacin Receptor Partial Agonists
#17150COMBINATION OF A HYPNOTIC AGENT AND R (+)-ALPHA-(2,3-DIMETHOXY-PHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL AND THERAPEUTIC APPLICATION THEREOF
#17151Treatment Of Stroke With Histamine H3 Inverse Agonists Or Histamine H3 Antagonists
#17152Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions
#17153Combinations Comprising Epothilones and Protein Tyrosine Kinase Inhibitors and Pharmaceutical Uses Thereof
#17154Method for healing a wound
#17155Inhibitors of bruton's tyrosine kinase
#17156Heterocyclic antiviral compounds
#17157METHODS FOR TREATMENT OF HEART DISEASE
#17158RE-EPITHELIALIZING PHARMACEUTICAL COMPOSITIONS COMPRISING XANTHAN GUM
#17159Use of megestrol acetate for improving heart function and the treatment of heart insufficiency
#17160Method for minimizing or avoiding adverse effects of vesicants
#17161Combination Therapies Employing Ace Inhibitors and Uses Thereof for the Treatment of Diabetic Disorders
#17162RE-EPITHELIALIZING PHARMACEUTICAL COMPOSITIONS COMPRISING XANTHAN GUM
#17163Agents containing folic acid, vitamin B6 and vitamin B12, and the use thereof
#17164Pharmaceutical Composition of Antiviral Agents
#17165Compositions comprising avermectin/azelaic acid compounds useful for treating, e.g., rosacea
#17166Flavonol-Based Medicine For Treating And/Or Preventing Endoprosthetic Restenosis And atheromatous Disease In Coronary Patients
#171671(Beta-D-Glycopyranosyl)-3-Substituted Nitrogenous Heterocyclic Compound, Medicinal Composition Containing the Same, and Medicinal Use Thereof
#17168DRUG COMBINATION FOR HYPERTENSIVE DISORDERS
#17169Intermediate duration neuromuscular blocking agents and antagonists thereof
#17170Combination Of (A) N--4-(3- Pyridyl)-2-Pyrimidine-Amine And (B) At Least One Hypusination Inhibitor And The UseThereof
#17171TREATMENT OF MEMBRANE-ASSOCIATED DISEASES AND DISORDERS USING LANTIBIOTIC CONTAINING COMPOSITIONS
#17172Methods of Treatment For Injured or Diseased Joints
#17173Therapeutic compositions comprising chorionic gonadotropins and HMG CoA reductase inhibitors
#17174Antimicrobial Compositions and Uses Thereof
#17175ANIMAL FEED COMPOSITION FOR INCREASED BIOACTIVITY AND PRODUCTION OF GLUTATHIONE PEROXIDASE AND SUPEROXIDE DISMUTASE
#17176Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs
#17177Dermatological composition
#17178Method for administering appetite suppressant and composition thereof
#17179Herbal Composition
#17180Method For Treating Bronchoconstriction and Pulmonary Vaso-Constriction
#17181Carnitine-Containing Peritoneal Dialysis Solution Having Improved Biocompatibility
#17182Food supplement composition suitable for promoting iron absorption
#17183Remedies for sex hormone dependent disease
#17184Nanoparticulate fibrate formulations
#17185Analgesic Compositions
#17186Topical Composition And Method Of Forming
#17187COMPOSITION AND METHOD FOR PRODUCING COMPOSITION FOR CONSTRUCTING TISSUE, AND TISSUE CONSTRUCT
#17188Methods of Regenerating Cartilage
#17189Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof
#17190Sustained release intraocular implants and related methods
#17191Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses
#17192Methods, treatments, and compositions for modulating Hedgehog pathways
#17193Macrocyclic lactone compounds and methods for their use
#17194LIPOSOME TREATMENT OF VIRAL INFECTIONS
#17195PROCESS FOR USE OF FLUOROQUINOLONES TO REDUCE OR MODULATE INFLAMMATION DUE TO EYE DISEASE OR OPHTHALMIC SURGERY
#17196CONNEXIN ENHANCES CHEMOTHERAPY-INDUCED APOPTOSIS IN HUMAN CANCER CELLS INHIBITING TUMOR CELL PROLIFERATION
#17197Removal of hypertrophic scars
#17198Methods and reagents for the enhancement of virus transduction in the bladder epithelium
#17199Use of a combination of cyclosporine and pegylated interferon for treating hepatitis C (HCV)
#17200Use of IL-22 for the treatment of conditions of metabolic disorders
#17201Methods for treating myelodysplastic syndrome with a human interleukin-3-diphtheria toxin conjugate
#17202Bechet's disease using cyclopropyl-N-carboxamide
#17203COMBINATIONS FOR TREATMENT OF NEOVASCULATURE
#17204Cartilage repair mixture containing allograft chondrocytes
#172051-thio-D-glucitol derivatives
#17206Methods for Treating Cancers Using Polymorphic Forms of 3-(4-Amino-1-Oxo-1,3 Dihydro-Isoindol-2-Yl)-Piperidine-2,6-Dione
#17207Tropane derivatives useful in therapy
#17208Pharmaceutical composition comprising a macrolide immunomodulator
#17209SYNERGISTIC COMBINATIONS OF NORKETAMINE AND OPIOID ANALGESICS
#17210Combination Of Cb2 Modulators And Pde4 Inhibitors For Use In Medicine
#17211Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
#17212Compounds for the treatment of psychiatric or substance abuse disorders
#17213Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
#17214Method for Inducing Mammary Epithelial Cell Differentiation
#17215Methods and compositions for modulating medial-lateral neuronal topographic maps
#17216Mixture of at Least 6 Species of Lactic Acid Bacteria and/or Bifidobacteria in the Manufacture of Sourdough
#17217COMPOSITION FOR TREATING ASTHMA
#17218SKIN PROTECTION COMPOSITION
#17219Konjac Mannan and Ginseng Compositions and Methods and Uses Thereof
#17220Composition comprising the extract of crude drug complex having neuroprotective activity for preventing and treating stroke and neurodegenerative diseases
#17221Chinese traditional medicine composition for treatment of avian influenza, method for preparation and application thereof
#17222METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING NEURODEGENERATIVE DISEASES
#17223Akt sensitization of cancer cells
#17224Therapeutic Nutrient Compositions Or Combinations And Methods Of Their Use
#17225Compositions for treatment of viral-induced skin lesions and methods of using same
#17226Antiviral and immune stimulant pharmaceutical composition
#17227Composition and method for providing localized delivery of a therapeutic agent
#17228Stable Pharmaceutical Composition Comprising a Fixed Dose Combination of Fenofibrate and an Hmg-Coa Reductase Inhibitor
#17229Mucinous glycoprotein (MUC-1) vaccine
#17230Sustained release intraocular implants and related methods
#17231Vaccination method for controlling coccidiosis in fowl
#17232Method and composition for reconforming multi-epitopic antigens to intiate an immune response
#17233METHOD FOR PREVENTING OR TREATING THE DEVELOPMENT OF RESPIRATORY ALLERGIES
#17234Isoflavone-containing composition
#17235Angiotensin I Derivatives
#17236COMBINATION THERAPY FOR TREATMENT OF VIRAL INFECTIONS
#17237Beta-2-glycoprotein 1 is an inhibitor of angiogenesis
#17238Method for altering the CD4/CD8 ratio and the mononuclear cellular infiltrate into a tumor
#17239Topical product formulations containing strontium for reducing skin irritation
#17240RS7 antibodies
#17241Methods and Compositions for Treating Lactose Intolerance
#17242Lactate Containing Pharmaceutical Composition and Uses Thereof
#17243Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ
#17244Stabilized ascorbic acid solutions; method of use thereof; process for their obtention; and compositions comprising the same
#17245(R,r)-Formoterol in Combination with Other Pharmacological Agents
#17246O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
#17247PHENYLEPHRINE TANNATE, PYRILAMINE TANNATE AND DEXTROMETHORPHAN TANNATE SALTS IN PHARMACEUTICAL COMPOSITIONS
#17248Combination Therapy
#17249CARDIOPROTECTIVE DELTA OPIOID RECEPTOR AGONISTS AND METHODS OF USING SAME
#17250Cathepsin K Inhibitors and Atherosclerosis
#17251Aryloxy-substituted benzimidazole derivatives
#17252Cancer Treatment Method
#17253Method of Treating Men with Metabolic and Anthropometric Disorders
#17254Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
#17255Use of estradiol valerate or 17β-estradiol in combination with dienogest for oral therapy to maintain and/or increase feminine libido
#17256Compositions and methods for the treatment of skin
#17257Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#17258Composition Comprising Pyy for the Treatment of Gastrointestinal Disorders
#17259NOVEL COMPOSITION CONTAINING EXTRACTS OF BUTYROSPERMUM PARKII AND THE USE OF SUCH A COMPOSITION FOR PREPARING A MEDICAMENT OR A DIETARY SUPPLEMENT FOR THE TREATMENT OR PREVENTION OF INFLAMMATION HYPERSENSITIVITY OR PAIN
#17260Throat Spray
#17261Topical Skin Compositions, Their Preparation, and Their Use
#17262Spray Mixture For Soothing A Cow Udder
#17263Deacetylase inhibitor therapy
#17264ALGAL AND ALGAL EXTRACT DIETARY SUPPLEMENT COMPOSITION
#17265Device and methods of sequential, regional delivery of multiple cyctotoxic agents and directed assembly of wound repair tissues
#17266Methods and Compositions for Treating Tumors
#17267Use of flagellin in the immunotherapy of
#17268Methods and compositions for treating melanoma
#17269Compositions and methods using anti-CS1 antibodies to treat multiple myeloma
#17270Conditioned Cell Immunization
#17271Nutritional composition comprising indigestible oligosaccharides
#17272Algae supplement and treatment method
#17273USE OF HYALURONIDASE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
#17274Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins
#17275Methods for isolating phage and for controlling microorganism populations with the phage
#17276Algae supplement and treatment method
#17277Thyroid hormone analogs and methods of use
#17278Methods of use of herbal compositions
#17279Treatment or prevention of cancer and precancerous disorders
#17280Combination Of Organic Compounds
#17281Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
#17282METHODS OF USING ARTEMISININ-LIKE COMPOUNDS TO PREVENT OR DELAY THE APPEARANCE OF CANCER
#17283Combinations comprising epothilones and pharmaceutical uses thereof
#17284Pyridoxamine for the treatment of diabetic intermediaries and post-amadori inhibition
#17285IMMEDIATE RELEASE OXYMORPHONE COMPOSITIONS AND METHODS OF USING SAME
#17286Combination Comprising Zd6474 And Imatinib
#17287METHODS FOR ENHANCING COGNITIVE FUNCTION
#17288Methods and compositions for the treatment of cancer
#17289Combination with bis(thiohydrazide amides) for treating cancer
#17290Regulation of oncogenes by microRNAs
#17291Combined use of PRAME inhibitors and HDAC inhibitors
#17292Process for treating a biological organism
#17293Orally administering parathyroid hormone and calcitonin
#17294Analogs of parathyroid hormone
#17295Unitary Combinations of FSH and hCG
#17296Method for treating wounds to promote healing
#17297Nutritional formula for athletes' recovery
#17298Modified two-component gelation systems, methods of use and methods of manufacture
#17299Bactericidal Formulations
#17300Using composition containing cAMP (cyclic adenosine monophosphate), nicotinic acid, prostaglandin, gamma linolenic acid and xanthines in weight loss and/or reducing elevated triglyceride
#17301Pharmaceutical formulations of rhodiola crenulata and methods of use thereof
#17302Anti-arthritic herbal composition and method thereof
#17303Anti-arthritic herbal composition and method thereof
#17304Medicated cream for topical application
#17305Renal phyto-nutraceutical composition
#17306Phyto-nutraceutical synergistic composition for Parkinson's Disease
#17307Immune phyto-neutraceutical composition
#17308Topical medicaments and methods for photodynamic treatment of disease
#17309Composition For Regulating Autonomic Nerves And Method For Using The Same
#17310PREDICTION OF AN AGENT'S OR AGENTS' ACTIVITY ACROSS DIFFERENT CELLS AND TISSUE TYPES
#17311Crystalloid electrolyte water formulation
#17312METHODS AND COMPOSITIONS FOR REDUCING THE RISK OF ADVERSE CARDIOVASCULAR EVENTS ASSOCIATED WITH THE ADMINISTRATION OF ARTIFICIAL BLOOD
#17313Modified release analgesic suspensions
#17314Pharmaceutical Composition Containing Candesartan Cilexetil as Lipophilic Crystalline Substance
#17315Modified Release of Compositions Containing a Combination of Carbidopa, Levodopa and Entacapone
#17316Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant
#17317Drug releasing coatings for medical devices
#17318Copper lowering treatment of inflammatory and fibrotic diseases
#17319Reagents and treatment methods for autoimmune diseases
#17320Uses and compositions for treatment of juvenile rheumatoid arthritis
#17321Method of treatment using protease
#17322Method for preventing or treating the development of respiratory allergies
#17323Method for preventing or treating the development of respiratory allergies
#17324Method for preventing or treating the development of respiratory allergies
#17325TREATING MOUTH ULCER WITH LIVE BACTERIA
#17326Hair undifferentiated cells
#17327Oncolytic adenoviral vectors encoding GM-CSF
#17328TREATMENT OF RHEUMATOID ARTHRITIS WITH SOLUBLE FAS-LIGAND CROSS-LINKERS
#17329Light Pharmaceutical Water and Therapeutic Compositions and Methods Thereof
#17330Diagnosis and treatment O prostate cancer
#17331Anti-atherosclerosis composition containing carotenoids and method for inhibiting LDL oxidation
#17332Synergistic Effects Of Docosahexaenoic Acid (DHA) And Carotenoid Absorption Of Cognitive Function
#17333Methods for the treatment of HIV-1 related fat maldistribution, fasting hyperlipidemia and modification of adipocyte physiology
#17334Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
#17335COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS OF THE MUCOSAE, SKIN AND THE EYE
#17336Compositions and methods for reducing antimicrobial resistance of microbes
#17337Pharmaceutical Combination of Angiotensin II Antagonists and Angiotensin I Converting Enzyme Inhibitors
#17338Method for treating delirium
#17339Cardiovascular compositions and methods using combinations of anti-platelet agents
#17340Enhancement of effectiveness of 5-Fluorouracil in treatment of tumor metastases and cancer
#173413-aryl-6-aryl-[ 1,2,4]triazolo[3,4-][1,3,4]thiadiazoles and related compounds as activators of caspases and inducers of apoptosis and the use thereof
#17342Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-2
#17343COMBINATION THERAPY FOR THE TREATMENT OF PAIN
#17344Combinations comprising a low molecular weight thrombin inhibitor and a prodrug of a low molecular weight thrombin inhibitor
#17345Combination Therapy For Treating Heart Disease
#17346Treatment of inflammatory, cancer, and thrombosis disorders
#17347Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin II antagonist for stroke prevention
#17348Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Psoriasis
#17349Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Rosacea
#17350N-aryl-5,7-dihydrofuro[3,4-d]pyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
#17351Compositions and methods for inhibiting cytochrome P450
#17352USE OF DIPYRIDAMOLE OR MOPIDAMOL FOR TREATMENT AND PREVENTION OF FIBRIN-DEPENDENT MICROCIRCULATION DISORDERS
#17353Abasic Oligonucleotide as Carrier Platform for Antigen and Immunostimulatory Agonist and Antagonist
#17354Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases
#17355Povidone-Containing Carriers for Polypeptide Growth Factors
#17356Uses Of Galectin-2
#17357Treatment of Neurological Conditions Using Complement C5a Receptor Modulators
#17358Use of ramoplanin to treat diseases associated with the use of antibiotics
#17359Use of an agent that restores tissue perfusion and oxygenation
#17360Pharmaceutical compositions and therapeutic applications for the use of a synthetic vitamin B12 derivative, glutathionylcobalamin
#17361Composition for enhancing male fertility
#17362PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT BASED ON COMBINATIONAL USE OF CONVENTIONAL ANTICANCER AGENTS AND GERANIUM OIL OR COMPOUNDS THEREOF
#17363Combination Therapy
#17364Composition For Promoting Osteogenesis And Increasing Bone Mineral Content
#17365TOPICAL TREATMENT AND MANUFACTURING METHOD
#17366Scalp Desensitizing Formulation
#17367Layered pharmaceutical formulations
#17368COMPOSITIONS COMPRISING NANOPARTICULATE NAPROXEN AND CONTROLLED RELEASE HYDROCODONE
#17369Methods and compositions for treating platelet-related disorders
#17370Bilayer tablet comprising telmisartan and diuretic
#17371Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
#17372Nonaqueous preparation for percutaneous absorption containing nonsteroidal anti-inflammatory analgesic
#17373Local administration of gallium compositions to treat pain
#17374Method for treatment of HIV infection
#17375NICOTINAMIDE COMPOSITIONS FOR TREATMENT OF SKIN DISEASES AND DISORDERS
#17376MN/CA IX and EGFR pathway inhibition
#17377Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy
#17378Synergistic compositions and methods for enhancing potency and/or for prolonging the duration of action of anesthetics
#17379COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTISM
#17380Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
#17381Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
#17382Augmentation and repair of spincter defects with cells including fibroblasts
#17383Methods and reagents for the enhancement of virus transduction in the bladder epithelium
#17384Methods and reagents for the enhancement of virus transduction in the bladder epithelium
#17385QS-21 and IL-12 as an adjuvant combination
#17386Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
#17387Sphingolipids' polyalkylamines conjugates
#17388METHODS FOR ADMINISTERING WEIGHT LOSS MEDICATIONS
#17389Methods and Compositions for Repairing Common Peroneal Nerve Lesions
#17390Methods for improving bioavailability of a renin inhibitor
#17391THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE AND TNF-ALFA PRODUCTION INHIBITOR
#17392Composition and its use as effective constituent of a medicine having anti-angiogenesis synergy effect
#17393Inhibitors of bruton's tyrosine kinase
#17394COMBINATION THERAPY FOR THE TREATMENT OF PAIN
#17395Modulators of pharmacokinetic properties of therapeutics
#17396COMBINATION THERAPY FOR THE TREATMENT OF PAIN
#17397Prevention of obesity in antipsychotic, antidepressant and antiepileptic medication
#17398New Use of Quetiapine
#17399Combination of Quetiapine and Zolmitriptan
#17400Method of treatment with coadministration of aspirin and prasugrel